Royal Treatment

Scientists in the U.K. will sequence the genome of King Richard III.

Written byTracy Vence
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

WIKIMEDIA, BRITISH SCHOOLThe remains of King Richard III, who died in 1485, were discovered beneath a parking lot in Leicester, U.K., in 2012, and their identity was confirmed last year. According to BBC News, the king’s final resting place has since been the subject of a legal battle. Before the medieval British monarch is reinterred, scientists from the University of Leicester are collecting bone samples from which to extract DNA, in the hopes of sequencing Richard III’s genome. The scientists will also sequence the genome of one of his living descendants, according to a Wellcome Trust statement.

“It is an extremely rare occurrence that archaeologists are involved in the excavation of a known individual, let alone a king of England,” the university’s Turi King, who is leading the project, said in the statement. “At the same time we are in the midst of a new age of genetic research, with the ability to sequence entire genomes from ancient individuals and, with them, those of pathogens that may have caused infectious disease.”

“The idea is that this will become a resource for people to look at,” King told the Los Angeles Times. As The Guardian noted, King told reporters that, once it’s complete, she and her colleagues plan to deposit Richard III’s genome sequence in a publicly accessible archive.

“We’re still in the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Screening 3D Brain Cell Cultures for Drug Discovery

Screening 3D Brain Cell Cultures for Drug Discovery

Explore synthetic DNA’s many applications in cancer research

Weaving the Fabric of Cancer Research with Synthetic DNA

Twist Bio 
Illustrated plasmids in bright fluorescent colors

Enhancing Elution of Plasmid DNA

cytiva logo
An illustration of green lentiviral particles.

Maximizing Lentivirus Recovery

cytiva logo

Products

The Scientist Placeholder Image

Sino Biological Sets New Industry Standard with ProPure Endotoxin-Free Proteins made in the USA

sartorius-logo

Introducing the iQue 5 HTS Platform: Empowering Scientists  with Unbeatable Speed and Flexibility for High Throughput Screening by Cytometry

parse_logo

Vanderbilt Selects Parse Biosciences GigaLab to Generate Atlas of Early Neutralizing Antibodies to Measles, Mumps, and Rubella

shiftbioscience

Shift Bioscience proposes improved ranking system for virtual cell models to accelerate gene target discovery